Deep Track Capital, LP Agenus Inc Transaction History

Deep Track Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.12 - $1.88 $1.9 Million - $3.19 Million	1,697,539 Added 5.66%	31,697,539 $35.8 Million
Q1 2023 May 15, 2023	BUY	$1.45 - $2.95 $4.35 Million - $8.85 Million	3,000,000 Added 11.11%	30,000,000 $45.6 Million
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.25 $1.36 Million - $2.19 Million	675,000 Added 2.56%	27,000,000 $64.8 Million
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $8 Million - $12.8 Million	4,083,583 Added 18.36%	26,325,000 $54 Million
Q2 2022 Aug 12, 2022	BUY	$1.3 - $2.64 $10.7 Million - $21.8 Million	8,242,926 Added 58.88%	22,241,417 $43.1 Million
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $32.9 Million - $48.6 Million	13,998,491 New	13,998,491 $34.4 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.